BrianChristopherBettsMD

Hematology • Minneapolis, MN

Hematologic Oncology

Physician

Join to view full profile

Dr. Betts is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Betts' full profile

Already have an account?

Office
909 Fulton St SE
Minneapolis, MN 55455
Phone+1 612-672-7422

Summary

Dr. Brian Betts is a hematologist in Minneapolis, MN and is affiliated with University of Minnesota. He received his medical degree from Eastern Virginia Medical School and has been in practice 16 years. He specializes in hematologic oncology and is experienced in graft-versus-host disease, stem cell transplantation, leukemia, and cell therapy.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
University of MinnesotaResidency, Internal Medicine, 2004 - 2007
Eastern Virginia Medical SchoolClass of 2004

Certifications & Licensure

NY State Medical License 2008 - 2025
MN State Medical License 2018 - 2024
FL State Medical License 2011 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results.
Joseph Pidala, Shernan G Holtan, Kelly Walton, Jongphil Kim, Biwei Cao
Blood. 2024-11-28
Novel Scoring System for Ranking Hematopoietic Stem Cell Transplantation.
Lee Ann Baxter-Lowe, Tao Wang, Michelle Kuxhausen, Stephen R Spellman, Martin Maiers
Clinical Transplantation. 2024-11-01
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients ...
Megan M Herr, Sophia R Balderman, Paul K Wallace, Yali Zhang, Joseph D Tario Jr
Transplantation and Cellular Therapy. 2024-08-01

Press Mentions

Pacritinib with Sirolimus/Tacrolimus Does Not Prevent Acute GVHDAugust 28th, 2024
VITRAC Therapeutics Initiates a Phase 1/2 Clinical Trial with the Aurora Kinase a Inhibitor VIC-1911 in GVHD ProphylaxisApril 26th, 2022
Experts in Transplantation, Engineered Cells and Pediatrics Join Growing Roswell Park Cell Therapy ProgramDecember 7th, 2023
Join now to see all